𝔖 Bobbio Scriptorium
✦   LIBER   ✦

bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice

✍ Scribed by Jansen, Burkhard; Schlagbauer-Wadl, Hermine; Brown, Bob D.; Bryan, Robert N.; Van Elsas, Andrea; Müller, Markus; Wolff, Klaus; Eichler, Hans-Georg; Pehamberger, Hubert


Book ID
109927266
Publisher
Nature Publishing Group
Year
1998
Tongue
English
Weight
458 KB
Volume
4
Category
Article
ISSN
1078-8956

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Bcl-xL antisense oligonucleotide and cis
✍ James E. Littlejohn; Xiaobo Cao; Steven D. Miller; Mustafa K. Ozvaran; Daniel Ju 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 702 KB

## Abstract Bcl‐xL functions as a dominant regulator of apoptotic cell death and is implicated in chemotherapeutic resistance of malignant pleural mesothelioma (MPM). Mesothelioma cell lines demonstrate increasing levels of Bcl‐xL as resistant clones are selected __invitro__. Moreover, upon introdu

Systemic Bcl-2 antisense oligodeoxynucle
✍ Jill Lacy; Regina Loomis; Susan Grill; Pavani Srimatkandada; Rocco Carbone; Yung 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 280 KB

## Abstract Nasopharyngeal carcinoma (NPC) is causally linked to Epstein‐Barr virus (EBV), and the EBV oncoprotein, latent membrane protein 1 (LMP‐1), is expressed in the majority of NPCs. LMP‐1 upregulates antiapoptotic genes, including __bcl‐2__, and Bcl‐2 protein is overexpressed in NPC. Given t